Panel Finds Drug Maker’s Statements Not To Be Materially Misleading
RICHMOND, Va. — A federal district court did not err in dismissing claims in a class action alleging that a clinical-stage biopharmaceutical company and certain of its current and former senior...To view the full article, register now.
Already a subscriber? Click here to view full article